Literature DB >> 6376264

Insulin degradation in hepatic cirrhosis.

J Ono, D G Hutson, R S Dombro, R Zeppa, T Katsuki.   

Abstract

Hepatic insulinase activity was studied in cirrhosis in an attempt to explain the hyperinsulinemia known to occur in this disease. Liver tissue was obtained during laparotomy in seven patients with cirrhosis of the liver and five patients without liver disease. Insulin degradation was significantly decreased in the cirrhotic liver at each time interval measured (p less than 0.05). Insulinase inhibitor activity was measured in the plasma of 12 patients with cirrhosis of the liver and six controls. There was no significant difference between the two groups. Decreased insulinase activity in cirrhosis may account, in part, for the hyperinsulinemia seen in this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376264     DOI: 10.1007/bf02806930

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  14 in total

1.  The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts.

Authors:  I A MIRSKY; R H BROH-KAHN
Journal:  Arch Biochem       Date:  1949-01

2.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

3.  Liver disease, insulin antagonism and diabetes mellitus.

Authors:  W Creutzfeldt; H Frerichs; P Kneer
Journal:  Horm Metab Res       Date:  1974       Impact factor: 2.936

4.  The role of 'insulinase' in the degradation of insulin.

Authors:  J H Thomas
Journal:  Postgrad Med J       Date:  1973-12       Impact factor: 2.401

5.  Insulin and glucose metabolism in liver cirrhosis and in liver failure.

Authors:  L Sestoft; J F Rehfeld
Journal:  Scand J Gastroenterol Suppl       Date:  1970

6.  Metabolic consequences of portacaval shunting in the rat: effects on glucose tolerance and serum immunoreactive insulin response.

Authors:  J P Assal; R Levrat; W Stauffacher; A E Renold
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694

7.  Plasma insulin after diversion of portal and pancreatic venous blood to vena cava.

Authors:  W R Waddell; K E Sussman
Journal:  J Appl Physiol       Date:  1967-04       Impact factor: 3.531

8.  Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog.

Authors:  M Kaden; P Harding; J B Field
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Dopamine and serotonin metabolism in hepatic encephalopathy.

Authors:  A J Knell; A R Davidson; R Williams; B D Kantamaneni; G Curzon
Journal:  Br Med J       Date:  1974-03-23

10.  Insulin degradation. XXVIII. Immunocytochemical localization of glutathione-insulin transhydrogenase in the pancreas, kidney and liver of normal and streptozotocin-diabetic rats and of lean and obese (ob/ob) mice.

Authors:  C A Taylor; P T Varandani
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

View more
  1 in total

Review 1.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.